Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.
about
A Phase I Study of Abiraterone Acetate Combined with BEZ235, a Dual PI3K/mTOR Inhibitor, in Metastatic Castration Resistant Prostate CancerAbiraterone Acetate: A Review in Metastatic Castration-Resistant Prostrate Cancer.Strategies to avoid treatment-induced lineage crisis in advanced prostate cancer.Impact of prior androgen receptor-axis-targeted agents on the clinical activity of subsequent docetaxel in patients with metastatic castration-resistant prostate cancer: comparative assessment between abiraterone acetate and enzalutamide.Current treatment strategies for advanced prostate cancer.No significant impact of response to prior androgen receptor-axis-targeted agents on the efficacy of subsequent docetaxel in patients with metastatic castration-resistant prostate cancer.
P2860
Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Subsequent Chemotherapy and Tr ...... st Hoc Analysis of COU-AA-302.
@en
Subsequent Chemotherapy and Tr ...... st Hoc Analysis of COU-AA-302.
@nl
type
label
Subsequent Chemotherapy and Tr ...... st Hoc Analysis of COU-AA-302.
@en
Subsequent Chemotherapy and Tr ...... st Hoc Analysis of COU-AA-302.
@nl
prefLabel
Subsequent Chemotherapy and Tr ...... st Hoc Analysis of COU-AA-302.
@en
Subsequent Chemotherapy and Tr ...... st Hoc Analysis of COU-AA-302.
@nl
P2093
P2860
P1433
P1476
Subsequent Chemotherapy and Tr ...... st Hoc Analysis of COU-AA-302.
@en
P2093
Charles J Ryan
Dana E Rathkopf
Eric J Small
Johann S de Bono
Mary B Todd
Matthew R Smith
Neal D Shore
Peter De Porre
P2860
P304
P356
10.1016/J.EURURO.2016.06.033
P407
P50
P577
2016-07-08T00:00:00Z